These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1778331)

  • 21. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Uberall MA; Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in pertussis immunisation in Japan.
    Kimura M; Kuno-Sakai H
    Lancet; 1990 Jul; 336(8706):30-2. PubMed ID: 1973217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups.
    Cherry JD; Mortimer EA; Hackell JG; Scott JV
    Dev Biol Stand; 1991; 73():51-8. PubMed ID: 1778334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of pertussis in Japan.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():1-7. PubMed ID: 3273609
    [No Abstract]   [Full Text] [Related]  

  • 26. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open study evaluating the reactogenicity and immunogenicity of a DTP vaccine containing an acellular pertussis component in four to six year old children.
    Lewis K; Cherry JD; Baraff LJ; Robinson RG; Dudenhoeffer FE; Holroyd HJ; Baker LR; Farchione SL; Gurwith M; Vernon S
    Dev Biol Stand; 1985; 61():563-9. PubMed ID: 2872132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-control study to evaluate the efficacy of the BIKEN acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) in infants.
    Beloradsky BH
    Dev Biol Stand; 1997; 89():70-3. PubMed ID: 9333574
    [No Abstract]   [Full Text] [Related]  

  • 30. Age at pertussis immunization as it relates to current epidemiology and disease control.
    Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
    Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absolute efficacy of acellular pertussis vaccines in household settings.
    Storsaeter J; Gustafsson L
    Dev Biol Stand; 1997; 89():153-9. PubMed ID: 9272345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of acellular pertussis vaccine in Japan--comparison of two areas, one area where immunization started at 6 months and the other area at over 2 years of age--Regional Surveillance Committee on Tuberculosis and Infectious Diseases of Osaka.
    Ohkuni H; Kitaura T; Tamai T; Takasugi Y; Sugimoto T; Fukai K
    Tokai J Exp Clin Med; 1988; 13 Suppl():51-4. PubMed ID: 3273619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study.
    Okada K; Ohashi Y; Matsuo F; Uno S; Soh M; Nishima S
    Epidemiol Infect; 2009 Jan; 137(1):124-30. PubMed ID: 18474125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experiences with acellular pertussis vaccine in Japan and epidemiology of pertussis.
    Kimura M; Kuno-Sakai H
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):263-73. PubMed ID: 3508651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of acellular pertussis vaccine in young infants.
    Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
    J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization.
    Kuno-Sakai H; Kimura M
    Pediatr Int; 2004 Dec; 46(6):650-5. PubMed ID: 15660862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Swedish efficacy trial of acellular pertussis vaccines--update and time for reflection.
    Olin P
    Dev Biol Stand; 1991; 73():33-6. PubMed ID: 1778327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids.
    Feldman S; Perry CS; Andrew M; Jones L; Moffitt JE; Lamb D; Meschievitz C
    South Med J; 1993 Mar; 86(3):269-75, 284. PubMed ID: 8451663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.